Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
Biomarkers
/ analysis
Body Mass Index
China
/ epidemiology
Female
Humans
Liver
/ diagnostic imaging
Liver Function Tests
/ methods
Male
Mass Screening
/ methods
Middle Aged
Non-alcoholic Fatty Liver Disease
/ blood
Polymorphism, Single Nucleotide
Prevalence
Reference Values
Risk Factors
Triglycerides
/ blood
Ultrasonography
Waist Circumference
gamma-Glutamyltransferase
/ blood
Body max index
Fatty liver index
Lean
Non-alcoholic fatty liver disease
Triglyceride
Waist circumference
Journal
World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448
Informations de publication
Date de publication:
21 Apr 2020
21 Apr 2020
Historique:
received:
25
12
2019
revised:
19
03
2020
accepted:
27
03
2020
entrez:
1
5
2020
pubmed:
1
5
2020
medline:
9
2
2021
Statut:
ppublish
Résumé
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic diseases in the world. Nowadays, the percentage of non-obese or lean patients with NAFLD is increasing. NAFLD in non-obese populations, especially the lean subgroup with a normal waist circumference (WC), might lead to more problems than obese individuals, as these individuals may not visit clinics for NAFLD diagnosis or ignore the diagnosis of NAFLD. If the precise characteristics of these populations, especially the lean subgroup, are identified, the clinicians would be able to provide more appropriate advice and treatment to these populations. To investigate the prevalence, clinical characteristics, risk factors, and possible indicators for NAFLD in lean Chinese adults with a normal WC. People without diabetes mellitus or significant alcohol consumption who underwent routine health examinations were included. Their fatty liver index (FLI), abdominal ultrasonography results, and controlled attenuation parameter were all assessed. Genotyping for single-nucleotide polymorphisms associated with NAFLD was performed in another small group consisting of biopsy-proven NAFLD subjects and healthy controls. A total of 2715 subjects who underwent routine health examinations were included in the study. Among 810 lean participants with a normal WC, 142 (17.5%) fulfilled the diagnostic criteria for NAFLD. Waist-height ratio, hemoglobin, platelets, and triglycerides were significant factors associated with the presence of NAFLD in these participants. The appropriate cut-off value of the FLI score in screening for NAFLD in the lean subjects with a normal WC was 25.15, which had a 77.8% sensitivity and 75.9% specificity. There was no significant difference in the single-nucleotide polymorphisms in the NAFLD is not uncommon in lean Chinese adults even with a normal WC. Metabolic factors, rather than genetic factors, may play important roles in the development of NAFLD in this population. A lower cut-off value of the FLI score in screening for NAFLD should be used for lean Chinese adults with a normal WC.
Sections du résumé
BACKGROUND
BACKGROUND
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic diseases in the world. Nowadays, the percentage of non-obese or lean patients with NAFLD is increasing. NAFLD in non-obese populations, especially the lean subgroup with a normal waist circumference (WC), might lead to more problems than obese individuals, as these individuals may not visit clinics for NAFLD diagnosis or ignore the diagnosis of NAFLD. If the precise characteristics of these populations, especially the lean subgroup, are identified, the clinicians would be able to provide more appropriate advice and treatment to these populations.
AIM
OBJECTIVE
To investigate the prevalence, clinical characteristics, risk factors, and possible indicators for NAFLD in lean Chinese adults with a normal WC.
METHODS
METHODS
People without diabetes mellitus or significant alcohol consumption who underwent routine health examinations were included. Their fatty liver index (FLI), abdominal ultrasonography results, and controlled attenuation parameter were all assessed. Genotyping for single-nucleotide polymorphisms associated with NAFLD was performed in another small group consisting of biopsy-proven NAFLD subjects and healthy controls.
RESULTS
RESULTS
A total of 2715 subjects who underwent routine health examinations were included in the study. Among 810 lean participants with a normal WC, 142 (17.5%) fulfilled the diagnostic criteria for NAFLD. Waist-height ratio, hemoglobin, platelets, and triglycerides were significant factors associated with the presence of NAFLD in these participants. The appropriate cut-off value of the FLI score in screening for NAFLD in the lean subjects with a normal WC was 25.15, which had a 77.8% sensitivity and 75.9% specificity. There was no significant difference in the single-nucleotide polymorphisms in the
CONCLUSION
CONCLUSIONS
NAFLD is not uncommon in lean Chinese adults even with a normal WC. Metabolic factors, rather than genetic factors, may play important roles in the development of NAFLD in this population. A lower cut-off value of the FLI score in screening for NAFLD should be used for lean Chinese adults with a normal WC.
Identifiants
pubmed: 32351294
doi: 10.3748/wjg.v26.i15.1792
pmc: PMC7183864
doi:
Substances chimiques
Biomarkers
0
Triglycerides
0
gamma-Glutamyltransferase
EC 2.3.2.2
gamma-glutamyltransferase, human
EC 2.3.2.2
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1792-1804Informations de copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Références
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1201-4
pubmed: 23353640
J Dig Dis. 2017 Apr;18(4):229-236
pubmed: 28296249
J Lipid Res. 2017 Jan;58(1):247-255
pubmed: 27836992
Gut Liver. 2016 Jan;10(1):117-25
pubmed: 26260755
J Hepatol. 2017 Oct;67(4):862-873
pubmed: 28642059
J Hepatol. 2009 Jan;50(1):204-10
pubmed: 19014878
Am J Gastroenterol. 2015 Sep;110(9):1306-14; quiz 1315
pubmed: 26215532
Liver Int. 2016 Feb;36(2):275-83
pubmed: 26176710
Am J Gastroenterol. 2013 Aug;108(8):1299-304
pubmed: 23567356
J Hepatol. 2012 Jan;56(1):241-7
pubmed: 21756851
World J Gastroenterol. 2016 Aug 21;22(31):7006-16
pubmed: 27610012
J Hepatol. 2015 Aug;63(2):494-502
pubmed: 25776890
J Hepatol. 2018 Oct;69(4):878-885
pubmed: 29802949
Hepatology. 2011 Jul;54(1):145-52
pubmed: 21488080
Hepatol Commun. 2017 Nov 30;2(1):48-57
pubmed: 29404512
Arch Med Res. 2013 Feb;44(2):115-20
pubmed: 23398788
Metabolism. 2019 Mar;92:82-97
pubmed: 30502373
Panminerva Med. 2018 Jun;60(2):41-43
pubmed: 29442484
J Hepatol. 2019 Mar;70(3):531-544
pubmed: 30414863
Ultrasonics. 2005 Mar;43(5):305-13
pubmed: 15737380
Am J Gastroenterol. 2018 Mar;113(3):376-383
pubmed: 29485130
Hepatology. 2015 Dec;62(6):1723-30
pubmed: 26274335
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Liver Int. 2014 Apr;34(4):604-11
pubmed: 24382309
J Gastroenterol Hepatol. 2012 Oct;27(10):1555-60
pubmed: 22741595
Gut. 2017 Jun;66(6):1138-1153
pubmed: 28314735
BMC Gastroenterol. 2006 Nov 02;6:33
pubmed: 17081293
Liver Int. 2019 Sep;39(9):1787
pubmed: 31081583
J Gastroenterol. 2011 Nov;46(11):1300-6
pubmed: 21750883